Kelin Zhang

582 total citations
22 papers, 457 citations indexed

About

Kelin Zhang is a scholar working on Molecular Biology, Cancer Research and Biomedical Engineering. According to data from OpenAlex, Kelin Zhang has authored 22 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Biomedical Engineering. Recurrent topics in Kelin Zhang's work include Liver Disease Diagnosis and Treatment (4 papers), Cancer-related molecular mechanisms research (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Kelin Zhang is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Cancer-related molecular mechanisms research (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Kelin Zhang collaborates with scholars based in China, United States and Singapore. Kelin Zhang's co-authors include Haixia Zhang, Xiaoyu Zhang, Xiujuan Guan, Changzhen Shang, Zhigang Xu, Wenliang Tan, Yajin Chen, Qing He, Xiaoyan Liu and Xiaojing Zhang and has published in prestigious journals such as Gene, Biosensors and Bioelectronics and Applied Surface Science.

In The Last Decade

Kelin Zhang

21 papers receiving 451 citations

Peers

Kelin Zhang
Stefania Porto Italy
Mingmei Liao China
Ana Brito Portugal
Mohammad Arad Zandieh Iran
Yanfang Wang China
Yinci Zhang China
Xuanming Chen China
Jiafeng Gao China
Xiaoxi Fan China
Stefania Porto Italy
Kelin Zhang
Citations per year, relative to Kelin Zhang Kelin Zhang (= 1×) peers Stefania Porto

Countries citing papers authored by Kelin Zhang

Since Specialization
Citations

This map shows the geographic impact of Kelin Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelin Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelin Zhang more than expected).

Fields of papers citing papers by Kelin Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelin Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelin Zhang. The network helps show where Kelin Zhang may publish in the future.

Co-authorship network of co-authors of Kelin Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Kelin Zhang. A scholar is included among the top collaborators of Kelin Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelin Zhang. Kelin Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Haixia, et al.. (2025). Severe immune-mediated myocarditis caused by sintilimab combined with gemcitabine: a case report and literature review. Frontiers in Cardiovascular Medicine. 12. 1559173–1559173. 2 indexed citations
2.
3.
Tan, Wenliang, Kelin Zhang, Xinming Chen, et al.. (2022). GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma. Journal of Advanced Research. 44. 173–183. 39 indexed citations
4.
He, Qing, Hao Peng, Gang He, et al.. (2022). IGF2BP1-regulated expression of ERRα is involved in metabolic reprogramming of chemotherapy resistant osteosarcoma cells. Journal of Translational Medicine. 20(1). 348–348. 22 indexed citations
5.
Huang, Xuelian, et al.. (2022). High Expression of Long Non-Coding RNA TMCO1-AS1 is Associated With Poor Prognosis of Hepatocellular Carcinoma. Frontiers in Molecular Biosciences. 9. 814058–814058.
6.
Liu, Lujie, Kelin Zhang, Jialin Lai, et al.. (2022). Neutrophil membrane-coated immunomagnetic nanoparticles for efficient isolation and analysis of circulating tumor cells. Biosensors and Bioelectronics. 213. 114425–114425. 36 indexed citations
7.
He, Qing, et al.. (2021). ERRα contributes to HDAC6-induced chemoresistance of osteosarcoma cells. Cell Biology and Toxicology. 39(3). 813–825. 6 indexed citations
8.
Li, Wenbin, Yue Zhu, Kelin Zhang, et al.. (2020). PROM2 promotes gemcitabine chemoresistance via activating the Akt signaling pathway in pancreatic cancer. Experimental & Molecular Medicine. 52(3). 409–422. 30 indexed citations
9.
Zhou, Xin, Wei Qin, Jie Zhu, et al.. (2020). Nϵ-Carboxymethyl-Lysine Deteriorates Vascular Calcification in Diabetic Atherosclerosis Induced by Vascular Smooth Muscle Cell-Derived Foam Cells. Frontiers in Pharmacology. 11. 626–626. 11 indexed citations
10.
Feng, Gong, Xueping Li, Chunyan Niu, et al.. (2020). Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Gene. 742. 144549–144549. 27 indexed citations
11.
Han, Xuliang, Xingming Ma, Linjie Liu, et al.. (2020). Protective effects of fisetin against myocardial ischemia/reperfusion injury. Experimental and Therapeutic Medicine. 19(5). 3177–3188. 18 indexed citations
12.
Zhang, Kun-Shui, et al.. (2019). Oestrogen‐related receptor alpha mediates chemotherapy resistance of osteosarcoma cells via regulation of ABCB1. Journal of Cellular and Molecular Medicine. 23(3). 2115–2124. 26 indexed citations
13.
Zhang, Kelin, et al.. (2019). LncRNA TNK2‐AS1 regulated ox‐LDL‐stimulated HASMC proliferation and migration via modulating VEGFA and FGF1 expression by sponging miR‐150‐5p. Journal of Cellular and Molecular Medicine. 23(11). 7289–7298. 26 indexed citations
14.
Huang, Xuelian, Kelin Zhang, Wenliang Tan, et al.. (2019). Low expression of long noncoding RNA CTC‐297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma. Cancer Medicine. 8(18). 7679–7692. 18 indexed citations
15.
Feng, Gong, Na He, Yifan Zhou, et al.. (2018). A simpler diagnostic formula for screening nonalcoholic fatty liver disease. Clinical Biochemistry. 64. 18–23. 10 indexed citations
16.
Zhang, Kelin, et al.. (2017). A technique for high precision temperature sensor. 680–683. 1 indexed citations
17.
Zhang, Kelin, et al.. (2016). A pH/glutathione double responsive drug delivery system using molecular imprint technique for drug loading. Applied Surface Science. 389. 1208–1213. 46 indexed citations
18.
19.
Xu, Zhigang, Kelin Zhang, Cuilan Hou, et al.. (2014). A novel nanoassembled doxorubicin prodrug with a high drug loading for anticancer drug delivery. Journal of Materials Chemistry B. 2(22). 3433–3437. 43 indexed citations
20.
Xu, Zhigang, Kelin Zhang, Xiaoyan Liu, & Haixia Zhang. (2013). A new strategy to prepare glutathione responsive silica nanoparticles. RSC Advances. 3(39). 17700–17700. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefania Porto Breakdown of academic impact, for papers by Mingmei Liao Breakdown of academic impact, for papers by Ana Brito Breakdown of academic impact, for papers by Mohammad Arad Zandieh Breakdown of academic impact, for papers by Yanfang Wang Breakdown of academic impact, for papers by Yinci Zhang Breakdown of academic impact, for papers by Xuanming Chen Breakdown of academic impact, for papers by Jiafeng Gao Breakdown of academic impact, for papers by Xiaoxi Fan
Rankless by CCL
2026